protein
| associated to surface IgM-receptor associating with PPP2CA, PPP2CB |
|
interacting with MID2 |
|
in addition to PPP2CA, IGBP1 interacts with UBR5 and PABPC1, suggesting its involvement in multiple steps in the MTOR pathway that leads to translation initiation and cell-cycle progression |
|
reduction of PPP2CA activity due to an enhanced IGBP1-PPP2CA interaction contributes directly to chemical carcinogen-induced tumorigenesis |
|
LTF binds IGBP1 and promotes the acceleration of cellular apoptosis |
|
IGBP1 interacts with MID1, a microtubule-associated ubiquitin E3 ligase that appears to regulate the function of PPP2CA |
|
role for MID1 in the regulation of IGBP1 that is likely to impact the stability and activity level of PPP2CA |
|
IGBP1 phosphoprotein binds to the protein phosphatase 2A catalytic subunit (PPP2CA) to regulate PP2A activity, and to poly(A)-binding protein (PABP) and progestin-inducible UBR5 |
|
MID1 catalyze the polyubiquitination of, IGBP1, a protein regulator of protein phosphatase 2A (PPP2CA) |
|
a significant fraction of total PPP6C is associated with IGBP1, whereas a minimal fraction of total PPP2CA is associated with IGBP1 |